| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.26 | 1e-05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-06 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.28 | 0.1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.29 | 0.09 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.3 | 0.1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.3 | 0.09 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | 0.3 | 0.09 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.33 | 0.08 |